Loeliger A.Prothrombin as co-factor of the circulating anticoagulant in systemic lupus erythematosus? Thrombos Diathes Haemorrh (Stuttg)1959; 3: 237-56.
2.
Yin ET, Gaston LWPurification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus. Thrombos Diathes Haemorrh (Stuttg)1965; 14: 88-115.
3.
Rivard GE, Schiffman S., Rapaport SICofactor of the 'lupus anticoagulant'. Thrombos Diathes Haemorrh (Stuttg)1974; 32: 554-63.
4.
Exner T., Rickard KA, Kronenberg H.A sensitive test demonstrating lupus anticoagulant and its behavioural patterns . Br J Haematol1978; 40: 143-51.
5.
McNeil HP, Simpson RJ, Chesterman CN, Krilis SAAntiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA1990; 87: 4120-4.
6.
Galli M., Comfurius P., Maassen C. et al. Anticardiolipin antibodies (ACA) are directed not to cardiolipin but to a plasma protein cofactor. Lancet1990 ; 335: 1544-7.
7.
Matsuura E., Igarashi Y., Fujimoto M., Ichikawa K., Koike T.Anticardiolipin cofactor(s) and differential diagnoses of autoimmune disease . Lancet1990; 336: 177-8.
8.
Bevers EM, Galli M.β2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin . Lancet1990; 336: 952-3.
9.
Loizou S., McCrea JD, Rudge AC et al. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay: standardization and quantitation of results. Clin Exp Immunol1985; 62: 738-44.
10.
Harris EN, Pierangeli S., Barquinero J., Ordi-Ros J.Anticardiolipin antibodies and binding of anionic phospholipids and serum protein. Lancet1990; 336: 505-6.
11.
Harris EN, Pierangeli S.What is the 'true' antigen for antiphospholipid antibodies?Lancet1990; 336: 1505.
12.
Proceedings of the workshop on β2-glycoprotein I, October 1991, Milan. Clin Exp Rheum (in press).
Schousboe I.Characterization of the interaction between β2-glycoprotein I and mitochondria, platelets, liposomes and bile acids. Int J Biochem1983; 15: 1393-1401.
15.
Lozier J., Takahashi N., Putnam FWComplete amino acid sequence of human plasma beta 2-glycoprotein I. Proc Natl Acad Sci USA1984; 81: 3640-4.
16.
Steinkasserer A., Estaller C., Weiss EH, Sim RBComplete nucleotide and deduced amino acid sequence of human β2-glycoprotein I. Biochem J1991; 277: 387-91 .
17.
Kroll J., Larsen JK, Loft H. et al. DNA-binding proteins in Yoshida ascites tumor fluid. Biochim Biophys Acta1976; 434: 490-501.
18.
Polz E.Isolation of a specific lipid binding protein from human serum by affinity chromatography using heparin-sepharose. In: Peeters H, ed. Protides of Biological Fluids. Oxford: Pergamon Press, 1979: 817-20.
19.
Schousboe I.Addition of deoxycholate in electroimmunoassay and crossed immunofocusing for quantification of β2-glycoprotein I and its subfractions. J Biochem Biophys Meth1982 ; 6: 105-14.
20.
Schousboe I.Binding of β2-glycoprotein I to platelets: effect on adenylate cyclase activity. Thromb Res1980; 19: 225-37.
21.
Nimpf J., Wurm H., Kostner GMInteraction of β2-glycoprotein I with human platelets: influence upon the ADP-induced aggregation. Thromb Haem1985 ; 54: 397-401 .
22.
Schousboe I., Rasmussen MSThe effect of β2-glycoprotein I on the dextran sulfate and sulfatide activation of the contact system (Hageman system) in the blood coagulation. Int J Biochem1988; 20: 787-92.
23.
Nimpf J., Bevers EM, Bomans PH, Till U., Kostner GM, Zwaal Rfa.Prothrombinase activity of human platelets is inhibited by β2-glycoprotein I. Biochim Biophys Acta1986; 884: 142-9.
24.
Exner T., Sahman N., Trudinger B.Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid polystyrene column. Biochem Biophys Res Commun1988; 155: 1001-7.
25.
McNeil HP, Chesterman CN, Krilis SAAnticardiolipin antibodies and lupus anticoagulants comprise antibody subgroups with different phospholipid binding characteristics. Br J Haematol1989; 73: 506-13.
26.
Bevers EM, Galli M., Barbul T., Comfurius P., Zwaal Rfa.Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost1991; 66: 629-32.
27.
Bevers EM, Comfurius P., Zwaal Rfa.Platelet procoagulant activity: physiological significance and mechanisms of exposure. Blood Reviews1991; 5: 146-54.